Position
Principal Accounting Officer
Company
AN2 Therapeutics
Menlo ParkBiotechnologyHealth CareScience And EngineeringDescription
On January 26, 2026, AN2 Therapeutics appointed Sarah Williams as Vice President, Controller and Principal Accounting Officer, effective February 1, 2026. Ms Williams previously served as the Company’s Corporate Controller since May 2024. She has extensive prior experience in the biotechnology sector, including roles at Gritstone Bio and Bio-Rad Laboratories.
Quick answer
AN2 Therapeutics Appoints Sarah Williams as New Vice President, Controller (January 29, 2026). AN2 Therapeutics is based in Menlo Park, California, United States.
- Who is the new Principal Accounting Officer at AN2 Therapeutics?
- AN2 Therapeutics named Sarah Williams Principal Accounting Officer, announced January 29, 2026.
- What did AN2 Therapeutics announce on January 29, 2026?
- On January 26, 2026, AN2 Therapeutics appointed Sarah Williams as Vice President, Controller and Principal Accounting Officer, effective February 1, 2026. Ms Williams previously served as the Company’s Corporate Controller since May 2024.
- What does AN2 Therapeutics do?
- AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform.
- Where is AN2 Therapeutics based?
- AN2 Therapeutics is based in Menlo Park, California, United States.
- Which similar companies made leadership changes around the same time?
- Cardiff Oncology (January 27, 2026), Bio-Techne Corporation (February 11, 2026), Charles River Laboratories (January 12, 2026) and Ray Therapeutics (February 17, 2026) also announced leadership changes within 45 days of AN2 Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cardiff Oncology Appoints Mani Mohindru as Interim Chief Executive Officer (January 27, 2026)
- Bio-Techne Announces Changes to Its Leadership Team (February 11, 2026)
- Charles River Laboratories Appoints Dr. Namandjé Bumpus as Chief Scientific and Innovation Officer (January 12, 2026)
- Ray Therapeutics Appoints Michael Murtagh as Chief Regulatory Officer (February 17, 2026)
- LIXTE Biotechnology Appoints Sidney Braun as Chief Executive Officer (February 18, 2026)
- Septerna Appoints Mark A. Wilson as Chief Legal Officer (January 8, 2026)
Who to call at AN2 Therapeutics, and when
A new leader at AN2 Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day AN2 Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AN2 Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AN2 Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AN2 Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AN2 Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.